Table 1.
Characteristics | Patients n (%) |
Year of the diagnosis of the first cancer | |
<1980 | 62 (51.2) |
1981–1990 | 48 (29.7) |
1991–1995 | 11 (9.1) |
Age at the diagnosis of the first cancer | |
<1 year | 2 (1.7) |
[1–5] years | 15 (12.4) |
[5–10] years | 9 (7.4) |
[10–15] years | 33 (27.3) |
[15–20] years | 32 (26.4) |
>20 years | 30 (24.8) |
First cancer | |
Hodgkin lymphoma | 76 (62.8) |
Nephroblastoma | 17 (14.0) |
Non-Hodgkin lymphoma | 7 (5.8) |
Neuroblastoma | 3 (2.5) |
Sarcoma | 8 (6.6) |
Acute leukemia, lymphoblastic lymphoma | 4 (3.3) |
Thyroid/oral and neck carcinoma | 2 (1.7) |
Medulloblastoma | 1 (0.8) |
Other | 3 (2.5) |
Chemotherapy | |
No | 20 (16.5) |
Yes | 96 (79.3) |
ND | 5 (4.1) |
Surgery | |
No | 83 (68.6) |
Yes | 38 (31.4) |
Pubertal stage at radiotherapy | |
Pre-puberty | 26 (21.5) |
Puberty | 20 (16.5) |
Post-puberty | 75 (62.0) |
Pregnancy in the 6 months before or after the radiotherapy | 3 (2.5) |
Radiotherapy | |
Field | |
Supradiaphragmatic (mediastinal, pulmonary, +–- axillary area) | 99 (81.8) |
Total body irradiation | 5 (4.1) |
Abdominal | 16 (13.2) |
Craniospinal | 1 (0.8) |
Maximal estimated dose on the breast (Gy) where SBC was diagnosed | |
<10 | 17 (14.0) |
[10–20] | 19 (15.7) |
>20 | 85 (70.2) |
Gy, Gray; ND, No data; SBC, second breast cancer.